Credit: Kindel Media from Pexels
A University of California, Riverside preclinical study is
shedding light on a long-observed but poorly understood phenomenon: chronic
cannabis users tend to have lower body weight and a reduced risk of developing
type 2 diabetes, despite the drug's well-known tendency to increase appetite.
Exploring the cannabis metabolism paradox
A team led by Nicholas V. DiPatrizio, a professor of biomedical sciences at
the UCR School of Medicine, set out to investigate this apparent paradox. While
cannabis is commonly associated with increased food intake—often referred to as
the "munchies"—population studies consistently show that regular
users exhibit improved metabolic profiles compared to non-users.
The new findings, published in The
Journal of Physiology, suggest that specific compounds within cannabis may
play a key role in regulating metabolism.
Comparing THC and whole-plant extract
Using a mouse model designed to mimic human dietary patterns, DiPatrizio and his team compared the effects of pure delta-9 tetrahydrocannabinol (THC)—the primary psychoactive component of cannabis—with a whole-plant cannabis extract containing the same level of THC alongside other naturally occurring compounds.
Graphical abstract. Credit: The Journal of Physiology (2026). DOI: 10.1113/jp290431
Both treatments led to significant weight loss in obese mice. However, the
metabolic outcomes differed dramatically.
Mice treated with THC alone showed no improvement in glucose regulation, a
key indicator of type 2 diabetes. Despite losing weight, these animals
continued to exhibit impaired glucose homeostasis, a hallmark of diabetes.
In contrast, mice treated with the whole cannabis extract not only lost
weight but also experienced a reversal of these metabolic impairments.
How cannabis compounds may restore signaling
"This suggests that THC alone is not responsible for the metabolic
benefits associated with cannabis use," said DiPatrizio, who directs the
UCR Center for Cannabinoid Research. "Other compounds in the plant appear
to play a critical role."
The researchers' analysis points to a potential mechanism involving
communication between fat tissue and the pancreas. In healthy systems, fat
cells release signaling molecules that help regulate insulin secretion from the
pancreas. In obesity and type 2 diabetes, this signaling becomes disrupted.
The study found that treatment with the full cannabis extract restored this
communication pathway better than THC alone, allowing fat tissue to signal the
pancreas and regulate blood glucose levels more effectively.
Caution, future therapies, and policy context
While the findings are promising, the researchers emphasize they do not
necessarily support the use of cannabis as a treatment for metabolic disease,
given that further research is needed in preclinical and human studies.
"We're not suggesting people should use cannabis to manage weight or
diabetes," DiPatrizio said.
DiPatrizio aims to identify non-psychoactive cannabis compounds for
targeted therapies that deliver metabolic benefits without THC's intoxicating
effects. Future studies will isolate and test individual compounds to pinpoint
those responsible.
The research also underscores the importance of continued scientific
investigation as cannabis use becomes more widespread and policies evolve.
"Clinicians, researchers, and policymakers should stay tuned and pay
attention to this space," DiPatrizio said. "We need evidence-based
approaches to fully understand both the risks and potential benefits of
cannabis and its components."
DiPatrizio was joined in the study by Bryant Avalos, Martin Olmos, Courtney P. Wood, Camila Alvarez, Haley M. Read, Parima Udompholkul, and Theodore Garland Jr.
Provided
by University
of California - Riverside
Source: Cannabis compounds beyond THC may help reverse metabolic problems during weight loss


No comments:
Post a Comment